K Kirito
Overview
Explore the profile of K Kirito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshimi A, Toya T, Nannya Y, Takaoka K, Kirito K, Ito E, et al.
Ann Oncol
. 2016 Feb;
27(5):887-95.
PMID: 26884589
Background: Inherited thrombocytopenia (IT) contains several forms of familial thrombocytopenia and some of them have propensity to hematological malignancies. The etiological and genetic features of this heterogeneous syndrome have not...
2.
Furukawa Y, Vu H, Akutsu M, Odgerel T, Izumi T, Tsunoda S, et al.
Leukemia
. 2007 Mar;
21(5):1005-14.
PMID: 17330105
FMS-like tyrosine kinase-3 (FLT3) is a new therapeutic target for acute myelocytic leukemia (AML), because FLT3 mutations are the most common genetic alterations in AML and are directly related to...
3.
Ohmine K, Ota J, Ueda M, Ueno S, Yoshida K, Yamashita Y, et al.
Oncogene
. 2002 Jan;
20(57):8249-57.
PMID: 11781839
Chronic myeloid leukemia (CML) is characterized by the clonal expansion of hematopoietic stem cells (HSCs). Without effective treatment, individuals in the indolent, chronic phase (CP) of CML undergo blast crisis...
4.
Miyazato A, Ueno S, Ohmine K, Ueda M, Yoshida K, Yamashita Y, et al.
Blood
. 2001 Jul;
98(2):422-7.
PMID: 11435312
Myelodysplastic syndrome (MDS) is a slowly progressing hematologic malignancy associated with a poor outcome. Despite the relatively high incidence of MDS in the elderly, differentiation of MDS from de novo...
5.
Uchida M, Kirito K, Shimizu R, Miura Y, Ozawa K, Komatsu N
Int J Hematol
. 2001 May;
73(1):78-83.
PMID: 11372759
The mitogen-activated protein (MAP) kinase cascade is a key regulator of mammalian cell proliferation and differentiation. In this study, we examined the roles of 2 members of the MAP kinase...
6.
Tanaka M, Kirito K, Kashii Y, Uchida M, Watanabe T, Endo H, et al.
J Biol Chem
. 2001 Mar;
276(18):15082-9.
PMID: 11278373
FKHRL1, a member of the Forkhead transcription factor family, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt. This molecule is a mammalian homolog of DAF-16, which plays an important...
7.
Muroi K, Tarumoto T, Akioka T, Kirito K, Nagai T, Izumi T, et al.
Intern Med
. 2000 Oct;
39(10):843-6.
PMID: 11030212
Flow cytometric, immunochemical and molecular studies were performed on leukemic blasts from a patient with minimally differentiated erythroleukemia (AML-M6v). The blasts expressed CD36 and CD71 but not lymphoid antigens, myeloid...
8.
Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M, et al.
Blood
. 2000 Jul;
96(3):941-9.
PMID: 10910908
The phosphatidylinositol 3-kinase (PI3K) signaling pathway is important for the regulation of a number of cellular responses. Serine/threonine kinase Akt (protein kinase B; PKB) is downstream of PI3K and activated...
9.
Komatsu N, Kirito K, Izumi T, Eguchi M, Miura Y
Exp Hematol
. 1998 Nov;
26(12):1148-54.
PMID: 9808054
We examined expression of the erythroid-associated genes GATA-1 and erythropoietin receptor (EPOR) in primary leukemia using the reverse transcriptase-polymerase chain reaction (RT-PCR). GATA-1 and EPOR mRNAs were detectable in all...
10.
Yamada M, Komatsu N, Kirito K, Kashii Y, Tomizuka H, Okada K, et al.
Cell Growth Differ
. 1998 Jul;
9(6):487-96.
PMID: 9663467
Thrombopoietin (TPO) acts on megakaryopoiesis and erythropoiesis in vitro and in vivo. We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood,...